The objective of this survey is to evaluate the safety and efficacy of fomepizole intravenous infusion in Japanese patients with ethylene glycol and methanol poisonings in daily medical practice.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants Reporting One or More Adverse Events (AEs)
Timeframe: From the first dose to 24 hours after the last dose of the drug (Up to approximately 11 days)
Number of Participants Who Had One or More Adverse Drug Reactions
Timeframe: From the first dose to 24 hours after the last dose of the drug (Up to approximately 11 days)
Number of Participants Reporting One or More Serious Adverse Events (SAEs)
Timeframe: From the first dose to 24 hours after the last dose of the drug (Up to approximately 11 days)
Number of Participants Who Had One or More Serious Adverse Drug Reactions
Timeframe: From the first dose to 24 hours after the last dose of the drug (Up to approximately 11 days)
Arterial Blood pH
Timeframe: Baseline, 4 hours after the first dose, and 24 hours after the last dose (Up to approximately 11 days)